Damar Celik Damla, Karaynir Abdulkerim, Salih Dogan Hanife, Bozdogan Bulent, Ozbek Celik Berna
Istanbul University Institute of Graduate Studies in Health Sciences Department of Pharmaceutical Microbiology, 34116, Beyazıt, Istanbul, Turkey.
Recombinant DNA and Recombinant Protein Research Center (REDPROM), Aydın Adnan Menderes University, Aydın, Turkey.
Heliyon. 2024 Aug 22;10(17):e36243. doi: 10.1016/j.heliyon.2024.e36243. eCollection 2024 Sep 15.
Phages are ubiquitous in freshwater, seawater, soil, the human body, and sewage water. They are potent biopharmaceuticals against antimicrobial-resistant bacteria and offer a promising alternative for treating infectious diseases. Also, combining phages with antibiotics enhances the antibiotics' efficacy. This study focused on two phages isolated from lake and sewage water samples and one of them selected for further investigation. Isolated phages PA-56 and PA-18 infected 92 % and 86 % of the tested 25 clinical strains, respectively. PA-56 with strong activity was chosen for detailed characterization, antimicrobial studies, and genome analysis. Combining PA-56 with ciprofloxacin or meropenem demonstrated phage-antibiotic synergism and increased antibiofilm efficacy. Genome analysis revealed a GC ratio of 54 % and a genome size of 42.761 bp, with no virulence or antibiotic resistance genes. Notably, PA-56 harboured the toxin-antitoxin protein, MazG. Overall, this study suggests that PA-56 holds promise for future applications in industry or medicine.
噬菌体在淡水、海水、土壤、人体和污水中普遍存在。它们是对抗耐药菌的强效生物药物,为治疗传染病提供了一种有前景的替代方案。此外,将噬菌体与抗生素结合可提高抗生素的疗效。本研究聚焦于从湖水和污水样本中分离出的两种噬菌体,并选择其中一种进行进一步研究。分离出的噬菌体PA - 56和PA - 18分别感染了测试的25株临床菌株中的92%和86%。选择活性较强的PA - 56进行详细表征、抗菌研究和基因组分析。将PA - 56与环丙沙星或美罗培南联合使用显示出噬菌体 - 抗生素协同作用,并提高了抗生物膜功效。基因组分析显示GC含量为54%,基因组大小为42761 bp,没有毒力或抗生素抗性基因。值得注意的是,PA - 56含有毒素 - 抗毒素蛋白MazG。总体而言,本研究表明PA - 56在未来工业或医学应用中具有潜力。